Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

355.57
-22.1400-5.86%
Post-market: 355.570.00000.00%19:30 EDT
Volume:264.58K
Turnover:95.51M
Market Cap:9.52B
PE:43.06
High:379.67
Open:373.87
Low:353.30
Close:377.71
52wk High:396.23
52wk Low:236.73
Shares:26.76M
Float Shares:22.32M
Volume Ratio:0.95
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.26
EPS(LYR):27.85
ROE:3.11%
ROA:1.66%
PB:1.33
PE(LYR):12.77

Loading ...

Bio-Rad’s Schwartz Reports 34.69% Voting Stake in Sartorius AG After Inheritance Event

Reuters
·
Sep 25

Biodesix Partners with Thermo Fisher on Tumor-Naïve MRD Blood Test Program

Reuters
·
Sep 24

Bio-Rad CFO Roop Lakkaraju Joins Bernstein Insights Healthcare Leaders and Disruptors Forum Fireside Chat

Reuters
·
Sep 16

Bio-Rad CFO Lakkaraju Joins Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Aug 31

BIO PORT KOREA Plans Multi-Day IR Roadshow to Highlight Q2 Results

TIPRANKS
·
Aug 24

KALA BIO Announces Brief Delay in Quarterly Filing

TIPRANKS
·
Aug 15

BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

GlobeNewswire
·
Aug 14

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

GlobeNewswire
·
Aug 13

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

GlobeNewswire
·
Aug 11

Imdx Reports Second Quarter 2026 Results and Timely Progress on FDA Review of Graftassuredx

THOMSON REUTERS
·
Aug 11

BIO-key, Visualforma awarded new contract by Portuguese national security agency

TIPRANKS
·
Aug 10

RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

GlobeNewswire
·
Aug 07

SAB BIO Q2 2026 Results: Clinical Spending Widens Net Loss

TradingKey
·
Aug 06

Press Release: SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Dow Jones
·
Aug 06

Bio-Rad Laboratories is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 06

RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Bio-Rad Laboratories, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Bio-Rad Laboratories to Cut Jobs, Close Facilities

Dow Jones
·
Aug 05

Bio-Rad Q2 Revenue Beats Analyst Estimates on Clinical Diagnostics Growth

Reuters
·
Aug 05